Clinical Trial

Bronchoscopic Microwave Ablation of Lung Tissue

Study acronym: AB1MALT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to evaluate the safety and feasibility of the Creo Medical MicroBlate™ Flex AB1 instrument used with the AB1 electrosurgical system in patients undergoing bronchoscopic microwave ablation of peripheral lung nodules.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-03-24; most recent amendment 2026-01-29.
Status change: Recruiting → Active, Not Recruiting 2026-01-29
Status change: Not Yet Recruiting → Recruiting 2023-05-18
Trial Details
NCT Number NCT05786625
Lead Sponsor Creo Medical Limited
Conditions Lung Cancer
Enrollment 35 participants
Start Date 2023-05-04
Primary Completion 2025-11-26 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-02